retatrutide weight loss clinical trial results Medscape | Retatrutide, Eli Lilly's first-in-class triple hormone receptor agonist, delivered meaningful at 80 weeks in all doses in the Demand for Unapproved Weight-Loss Drug

Current Diabetes Reports

As youre considering your options, its important to understand that obesity is a chronic medical condition not a willpower issue

The following history attempts to correct the traditional narrative by capturing some of the women's voices and the many different roles they played alongside male colleagues in shaping the development of GLP-1 drugs

Weight regain after bariatric surgery: scope of the problem, causes, prevention, and treatment

The mouth and the body are deeply connected and GLP-1 medications may be one of the clearest examples of how treating one part of your health can unexpectedly improve another. How GLP-1s May Affect Teeth Grinding and TMJ Theres also a more straightforward connection through sleep